Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Liver Elastography for Methotrexate-Induced Fibrosis
6
Mins
March 2024
Methotrexate (MTX), an antimetabolite, has a multifarious mechanism of action that most notably includes folate antagonism, effects on…
Read more
11
Mins
19th December 2022
Nothing About Me Without Me: Shared Decision-Making in Chronic Hepatitis B
Hepatitis B affects more than 296 million people worldwide, according to the World Health Organization (WHO). More than 1.5 million new infections occur each year, despite the availability of safe and effective vaccines.
13
Mins
26th August 2022
Recent Findings in the Gut-Liver Axis and Associated Disease Therapy
Several presentations at the recent International Liver Congress™ (ILC), held in London, UK, from 22nd–26th of June 2022, addressed the role of the gut microbiome in chronic liver disease.
10
Mins
4th August 2022
Holistic Patient Care in Primary Biliary Cholangitis
PBC is an immune-mediated, chronic, progressive liver disease characterised by gradual destruction of intrahepatic bile ducts.
9
Mins
4th August 2022
Paediatric Acute-on-Chronic Liver Failure
There is growing recognition of acute-on-chronic liver failure (ACLF) as a distinct clinical syndrome that portends excessively high…
10
Mins
4th August 2022
Non-alcoholic Steatohepatitis: Global Impact and Clinical Consequences
Non-alcoholic steatohepatitis (NASH) is the potentially progressive form of non-alcoholic fatty liver disease (NAFLD). NAFLD and NASH are very common in most regions of the world and are on trajectory to become the most common liver disease at a global scale. Risk for high prevalence and progressiveness include visceral obesity and Type 2 diabetes.
4
Mins
4th August 2022
Post-traumatic Isolated Right Hepatic Duct Injury: A Case Report
A 73-year-old female presented with a rare presentation of extrahepatic ductal injuries post-trauma in the form of a right hepatic duct injury. Such injuries go undetected despite normally advised imaging, presenting a few to several days post-trauma.
11
Mins
26th April 2022
The Impact of Paediatric Cholestatic Liver Disease: Diagnosis, Management, and Treatment Considerations
Cholestatic liver diseases are the leading indications for paediatric liver transplant, and result in significant morbidity and mortality.
6
Mins
11th April 2022
Interview: Charlotte Scott
I have always been curious, wanting to understand how and why everything works. My interest in biology began in secondary school in Ireland, where I had a very energetic teacher, Mr Whisker.
Loading posts...
« Previous
1
2
3
4
…
16
Next »